Uh, do you mean aside from the obvious problem that a short duration trial may not access efficacy or long-term tolerability sufficiently for the treatment of a chronic disease state?
Uh, do you mean aside from the obvious problem that a short duration trial may not access efficacy or long-term tolerability sufficiently for the treatment of a chronic disease state?